Grounded in the neurosciences, the CANTAB® neuropsychological tests were developed more than 21 years ago at the University of Cambridge by Professors Robbins and Sahakian, to enable detailed translational assessment and evaluation of cognitive function. Lesion, neuroimaging, clinical and psychopharmacological studies have enabled a unique understanding of the structural, clinical and biochemical sensitivities of each of the tests.
CANTAB, commercialised in 1994, has become the world leader in computerised cognitive testing in its field. It has been used by more than 500 academic institutions worldwide and quoted in over 600 scientific papers. This immense body of work stretching back over the last 21+ years gives CANTAB an unrivalled scientific heritage and degree of validation. |
CANTAB tests are sensitive to cognitive changes caused by a wide range of CNS disorders and medication effects.
Where error scores are a key outcome measure, CANTAB tests are graded in difficulty to avoid ceiling effects.
Where accurate measurement of latency is important, responses are made via a press pad. Elsewhere, engaging touch-screen technology maximises compliance.
The majority of CANTAB tests are independent of language and culture.
Conference Watch
Keep up to speed with what's happening in your area of research or practice with our world-wide conference watch.
| Conferences |
26/05/2010 | APS 22nd Annual Convention - 2010
This year's conference theme is "Revolutionary Science".... |
13/06/2010 | 46th DIA Annual Meeting
The DIA Annal Meeting is the biopharmaceutical industry's largest global, multidisciplinary event, f... |
03/07/2010 | 7th FENS Forum of European Neuroscience
The FENS Forum is the main European neuroscience meeting, covering disciplines from molecular techni... |
25/07/2010 | BAP 2010 Summer Meeting
The BAP was founded in 1974, with the general intention of bringing together those from clinical and... |
|
|
